Skip to content

Turmeric supplementation on symptoms of dysmenorrhea

Effect of Turmeric supplementation on symptoms of primary dysmenorrhea in resident students at Qazvin University of Medical Sciences student dormitory: A randomized, one-blind, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141025019669N9
Enrollment
80
Registered
2018-03-07
Start date
2018-04-09
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Turmeric, 600 mg per daily. Intervention 2: Intervention group: Mefenamic acid, 250 mg per day. Intervention 3: Intervention group: Turmeric (500 mg) + Mefenamic ac

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Having primary dysmenorrhea Having regular menstruation between 35-21 days Single Having a body mass index below 30 Having aged 18 to 25 years old

Exclusion criteria

Exclusion criteria: Having secondary dysmenorrhea (endometriosis, adenomyosis, leiomyoma, uterine anomaly, Endometrial Polyps, ovarian cyst) Intake of antioxidant supplement in the last six months

Design outcomes

Primary

MeasureTime frame
Duration of bleeding. Timepoint: Before the intervention and after the intervention. Method of measurement: According to a person's report by the questionnaire.;Pain duration. Timepoint: Before the intervention and after the intervention. Method of measurement: Duration of pain based on hours.;Intensity of pain. Timepoint: Before the intervention and after the intervention. Method of measurement: Pain intensity according to the questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Khadem Haghighian

Qazvin University of Medical Sciences

khademnut@yahoo.com+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026